Chronic neuropathic pain remains one of the most challenging conditions to treat, with current therapies offering limited benefit and being over-reliant on opioids. Researchers at Rensselaer Polytechnic Institute (RPI), along with collaborators from the University of Sydney and the University of Copenhagen, have developed an approach that offers a clearer path toward safer, non-addictive pain therapies.
This article was originally published on MedicalXpress.com

